Nuvilex, Inc. Names Two Significant Partners on Its Way to Phase 3 Clinical Trials NEW YORK, NY--(Marketwired - Sep 19, 2013) - Nuvilex, Inc. (OTCQB: NVLX) made another subtle but significant move this week that seems to signal the company is in "go-mode" on its future Phase III...